Evaluating the predictive value of biomarkers with stratified case-cohort design
From MaRDI portal
Publication:4911947
Recommendations
- Robust risk prediction with biomarkers under two-phase stratified cohort design
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- Assessing incremental value of biomarkers with multi-phase nested case-control studies
- Nonparametric maximum likelihood estimators of time-dependent accuracy measures for survival outcome under two-stage sampling designs
- Evaluating prognostic accuracy of biomarkers in nested case-control studies
Cites work
- A case-cohort design for epidemiologic cohort studies and disease prevention trials
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Exposure stratified case-cohort designs
- scientific article; zbMATH DE number 51427 (Why is no real title available?)
- scientific article; zbMATH DE number 3385132 (Why is no real title available?)
- Nonparametric Survival Estimation Using Prognostic Longitudinal Covariates
- On fitting Cox's proportional hazards models to survey data
- Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes
- Smoothed Cox regression
- Survival Model Predictive Accuracy and ROC Curves
- Time-Dependent Predictive Values of Prognostic Biomarkers With Failure Time Outcome
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
- Weighted analyses for cohort sampling designs
- Weighted Estimators for Proportional Hazards Regression With Missing Covariates
- Weighted Likelihood for Semiparametric Models and Two‐phase Stratified Samples, with Application to Cox Regression
Cited in
(15)- Biomarker assessment and combination with differential covariate effects and an unknown gold standard, with an application to Alzheimer's disease
- Estimation of covariate-specific time-dependent ROC curves in the presence of missing biomarkers
- Assessing incremental value of biomarkers with multi-phase nested case-control studies
- Evaluating prognostic accuracy of biomarkers in nested case-control studies
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- Comparing costs associated with risk stratification rules for t-year survival
- Nonparametric maximum likelihood estimators of time-dependent accuracy measures for survival outcome under two-stage sampling designs
- Robust risk prediction with biomarkers under two-phase stratified cohort design
- Kernel machine testing for risk prediction with stratified case cohort studies
- Subgroup specific incremental value of new markers for risk prediction
- Regularized regression for two phase failure time studies
- Two-stage receiver operating-characteristic curve estimator for cohort studies
- Improving efficiency and robustness of the prognostic accuracy of biomarkers with partial incomplete failure-time data and auxiliary outcome: application to prostate cancer active surveillance study
- Estimating time-dependent ROC curves using data under prevalent sampling
- Two-phase designs for cost-effective evaluation of cancer screening tests
This page was built for publication: Evaluating the predictive value of biomarkers with stratified case-cohort design
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4911947)